EUVIMEDEUVIMED entdecken
Open Access

Changes in the Appropriateness of US Outpatient Antibiotic Prescribing After the COVID-19 Outbreak: An Interrupted Time Series Analysis of 2017–2021 Data

Kao-Ping Chua iD, Michael A Fischer, Moshiur Rahman, Jeffrey A Linder

Clinical Infectious Diseases · 16.08.2024 · 79 (2) · 312-320

DOI: 10.1093/cid/ciae135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 22.04.2024. Verfasst von Kao-Ping Chua und 3 weiteren Autor:innen. Beteiligte Einrichtung: Susan B. Meister Child Health Evaluation and Research Center, Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Interrupted Time Series Analysis, COVID-19, Inappropriate Prescribing. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, AHRQ HHS, NIDA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

No national study has evaluated changes in the appropriateness of US outpatient antibiotic prescribing across all conditions and age groups after the coronavirus disease 2019 (COVID-19) outbreak in March 2020.

Methods

This was an interrupted time series analysis of Optum's de-identified Clinformatics Data Mart Database, a national commercial and Medicare Advantage claims database. Analyses included prescriptions for antibiotics dispensed to children and adults enrolled during each month during 2017–2021. For each prescription, we applied our previously developed antibiotic appropriateness classification scheme to International Classification of Diseases, Tenth Revision, Clinical Modification diagnosis codes on medical claims occurring on or during the 3 days prior to dispensing. Outcomes included the monthly proportion of antibiotic prescriptions that were inappropriate and the monthly proportion of enrollees with ≥1 inappropriate prescription. Using segmented regression models, we assessed for level and slope changes in outcomes in March 2020.

Results

Analyses included 37 566 581 enrollees, of whom 19 154 059 (51.0%) were female. The proportion of enrollees with ≥1 inappropriate prescription decreased in March 2020 (level decrease: −0.80 percentage points [95% confidence interval {CI}, −1.09% to −.51%]) and subsequently increased (slope increase: 0.02 percentage points per month [95% CI, .01%–.03%]), partly because overall antibiotic dispensing rebounded and partly because the proportion of antibiotic prescriptions that were inappropriate increased (slope increase: 0.11 percentage points per month [95% CI, .04%–.18%]). In December 2021, the proportion of enrollees with ≥1 inappropriate prescription equaled the corresponding proportion in December 2019.

Conclusions

Despite an initial decline, the proportion of enrollees exposed to inappropriate antibiotics returned to baseline levels by December 2021. Findings underscore the continued importance of outpatient antibiotic stewardship initiatives.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsInterrupted Time Series AnalysisCOVID-19Inappropriate PrescribingHumansFemaleMaleUnited StatesAgedMiddle AgedChildAdultAdolescentChild, PreschoolYoung AdultOutpatientsInfantAged, 80 and overSARS-CoV-2Drug PrescriptionsInfant, NewbornAntimicrobial StewardshipPractice Patterns, Physicians'

Stichwörter der Autor:innen

COVID-19antibiotic stewardshipantibioticsprescription drugsquality

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Susan B. Meister Child Health Evaluation and Research Center, Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Department of Health Management and Policy, University of Michigan School of Public Health, Ann Arbor, MI, USA.
  • Section of General Internal Medicine, Boston Medical Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.
  • Division of General Internal Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

ORCID-Profile: Kao-Ping Chua

Förderung

  • NIA NIH HHS
  • AHRQ HHS
  • NIDA NIH HHS
  • NIH HHS
  • National Institute on Drug Abuse
  • National Institute on Aging
  • Agency for Healthcare Research and Quality
  • National Institutes of Health

Zitieren

APA

Chua, K. P., Fischer, M. A., Rahman, M., & Linder, J. A. (2024). Changes in the Appropriateness of US Outpatient Antibiotic Prescribing After the COVID-19 Outbreak: An Interrupted Time Series Analysis of 2017–2021 Data. Clinical Infectious Diseases, 79(2), 312-320. https://doi.org/10.1093/cid/ciae135

Vancouver

Chua KP, Fischer MA, Rahman M, Linder JA. Changes in the Appropriateness of US Outpatient Antibiotic Prescribing After the COVID-19 Outbreak: An Interrupted Time Series Analysis of 2017–2021 Data. Clinical Infectious Diseases. 2024;79(2):312-320. doi:10.1093/cid/ciae135

BibTeX
@article{Chua2024,
  author = {Chua, Kao-Ping and Fischer, Michael A and Rahman, Moshiur and Linder, Jeffrey A},
  title = {Changes in the Appropriateness of US Outpatient Antibiotic Prescribing After the COVID-19 Outbreak: An Interrupted Time Series Analysis of 2017–2021 Data},
  journal = {Clinical Infectious Diseases},
  year = {2024},
  volume = {79},
  number = {2},
  pages = {312--320},
  doi = {10.1093/cid/ciae135}
}
Kostenlos starten →